Efficacy of bupropion and varenicline genetic markers in choosing pharmacological treatment for smoking cessation, and implications for combining drugs: A randomized controlled trial (GENTSMOKING)

Introduction Smoking cessation is the best strategy for reducing tobacco-related morbimortality. The goal of this randomized controlled trial was to test whether using the genetically favorable markers to choose a smoking cessation drug treatment (precision medicine) was superior to using the most e...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Patricia V. Gaya, Juliana R. Santos, Paulo R. X. Tomaz, Tania M. O. Abe, Miguel Nassif Jr, Larissa G. Galas, Bianca B. Bellini, Iana R. Moraes, Paulo C. Lima Santos, Paulo C. R. P. Correa, Jaqueline R. Scholz
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	European Publishing 2024-04-01
Serie:	Tobacco Induced Diseases
Soggetti:	precision medicine varenicline bupropion smoking cessation pharmacogenetics
Accesso online:	https://www.tobaccoinduceddiseases.org/Efficacy-of-bupropion-and-varenicline-genetic-markers-in-choosing-pharmacological,186072,0,2.html
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!